News|Articles|April 9, 2025
Evolving Complexities In BioAnalysis: Addressing Sensitivity, Selectivity and Sample Complexity
Author(s)Sannova Analytical
Evolving therapeutic modalities increase bioanalytical complexity, making ion mobility spectrometry–mass spectrometry (IMS-MS) crucial for enhanced sensitivity and selectivity.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
2
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
3
Novartis Calls for Global Governments to Address Global Trade Policy
4